These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3839576)
21. Primary rhabdomyosarcoma of urethra in a 5-year-old girl: case report and literature review. Liu AX; Zhou JH; Jin HM; Zhu CK; Cheng XD Urology; 2007 Jun; 69(6):1208.e17-9. PubMed ID: 17572220 [TBL] [Abstract][Full Text] [Related]
22. The role of pelvic exenteration for sarcomatous malignancies. Reid GC; Morley GW; Schmidt RW; Hopkins MP Obstet Gynecol; 1989 Jul; 74(1):80-4. PubMed ID: 2733946 [TBL] [Abstract][Full Text] [Related]
23. Embryonal rhabdomyosarcoma of the uterine cervix in a 41-year-old woman treated with radical hysterectomy and adjuvant chemotherapy. Sanders MA; Gordinier M; Talwalkar SS; Moore GD Gynecol Oncol; 2008 Dec; 111(3):561-3. PubMed ID: 18725166 [TBL] [Abstract][Full Text] [Related]
24. [Paratesticular rhabdomyosarcoma: a case report]. Chiba K; Kitami K; Kumagai H Hinyokika Kiyo; 1990 Mar; 36(3):363-6. PubMed ID: 2191575 [TBL] [Abstract][Full Text] [Related]
25. [A infant case of rhabdomyosarcoma arising from the left iliac region with complete remission for 2 years after combination therapy]. Shimabuku M; Muto Y; Hokama A; Tokumine F; China K; Gushiken T; Sonan S; Hirayama K; Toda T Gan To Kagaku Ryoho; 1993 Apr; 20(5):657-60. PubMed ID: 8470926 [TBL] [Abstract][Full Text] [Related]
26. [Pediatric rhabdomyosarcoma of the infratemporal fossa]. Rozan O; Janot F; Oberlin O; Schwaab G; Quintana E; Tran Ba Huy P; Georges B; Luboinski B Ann Otolaryngol Chir Cervicofac; 2002 Sep; 119(4):195-201. PubMed ID: 12410115 [TBL] [Abstract][Full Text] [Related]
27. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472 [TBL] [Abstract][Full Text] [Related]
29. Embryonal rhabdomyosarcoma of the female genital tract: 5 years' experience. Hemida R; Goda H; Abdel-Hady el-S; El-Ashry R J Exp Ther Oncol; 2012; 10(2):135-7. PubMed ID: 23350353 [TBL] [Abstract][Full Text] [Related]
30. [Rhabdomyosarcoma of the prostate: report of a case and review of the literature]. Seino K; Tanji S; Yamamoto T; Fujizuka I; Ohinata M; Kubo T; Ohhori T Hinyokika Kiyo; 1987 Nov; 33(11):1906-12. PubMed ID: 3328512 [TBL] [Abstract][Full Text] [Related]
31. [The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy]. Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Iantorno D; Brach Del Prever A; Ruggieri P; Forni C Minerva Chir; 1997 Apr; 52(4):415-26. PubMed ID: 9265127 [TBL] [Abstract][Full Text] [Related]
32. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. Orbach D; Rey A; Oberlin O; Sanchez de Toledo J; Terrier-Lacombe MJ; van Unnik A; Quintana E; Stevens MC J Clin Oncol; 2005 Jul; 23(19):4363-71. PubMed ID: 15994146 [TBL] [Abstract][Full Text] [Related]
33. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Koscielniak E; Klingebiel TH; Peters C; Hermann J; Burdach ST; Bender-Götze C; Müller-Weihrich ST; Treuner J Bone Marrow Transplant; 1997 Feb; 19(3):227-31. PubMed ID: 9028550 [TBL] [Abstract][Full Text] [Related]
34. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation. Paulino AC; Bauman N; Simon JH; Nguyen TX; Ritchie JM; Tannous R Med Pediatr Oncol; 2003 Aug; 41(2):118-22. PubMed ID: 12825215 [TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Oberlin O; Deley MC; Bui BN; Gentet JC; Philip T; Terrier P; Carrie C; Mechinaud F; Schmitt C; Babin-Boillettot A; Michon J; Br J Cancer; 2001 Nov; 85(11):1646-54. PubMed ID: 11742482 [TBL] [Abstract][Full Text] [Related]
36. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience. Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446 [TBL] [Abstract][Full Text] [Related]
37. Primary chemotherapy in the treatment of children with bladder--prostate tumors in the Intergroup Rhabdomyosarcoma Study (IRS-II). Hays DM; Raney RB; Lawrence W; Tefft M; Soule EH; Crist WM; Foulkes M; Maurer HM J Pediatr Surg; 1982 Dec; 17(6):812-20. PubMed ID: 6761418 [TBL] [Abstract][Full Text] [Related]
38. Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma. Sulis ML; Bessmertny O; Granowetter L; Weiner M; Kelly KM J Pediatr Hematol Oncol; 2004 Dec; 26(12):843-6. PubMed ID: 15591910 [TBL] [Abstract][Full Text] [Related]